set to surge oversold with huge potential, page-8

Unfortunately, I have not done any further analysis regarding the potential value of the ketamine test. Could prove quite a nice little earner if HGR can be the first to market with a user-friendly, highly accurate and affordable test kit. But at what cost of R&D and approval (FDA?) prior to release?

As for the urine tests, I can't see that being a great earner for HGR, but it I suppose it could bring some needed cashflow. Any sales, however, would like be at very low profit margins given there are so many other competing manufacturers in this space (including large pharmas). Therefore I can't see how HGR would have any sort of competitive advantage or edge here to compete effectively in this particular category. A price/benefits comparative assessment of their product vs "the Others" would probably tell the story better.